Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Latest News

Jennifer Brown, MD, PhD, Dana-Farber Cancer Institute

August 23rd 2023

Dr Jennifer Brown Discusses Zanubrutinib Uptake in CLL, SLL

Jennifer Brown, MD, PhD, director of the Chronic Lymphocytic Leukemia Center at Dana-Farber Cancer Institute, discussed the uptake of zanubrutinib for the treatment of chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL).

August 3rd 2023

Emory’s Jonathan Cohen, MD, Traces Evolution in CLL Therapy

By Mary Caffrey

June 11th 2023

Researchers Deliver Updates on Efforts Toward Eradicating CLL

By Christina Mattina

June 10th 2023

Long-Term Data Show QOL Advantage of Zanubrutinib in 3 Cancers

By Christina Mattina

Navigating Policy & Utilization Management in Oncology: Aligning Evidence with Access

Experts discuss how policy shifts, payer strategies, and utilization-management practices affect oncology access and evidence-based care.

Watch Now

Navigating Policy & Utilization Management in Oncology: Aligning Evidence with Access

CME Content

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management